Your SlideShare is downloading. ×
0
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Mh11 sim
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Mh11 sim

427

Published on

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
427
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
38
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. !"#$%&%()*+,#&-./(0,12#*3#4&5(64+ 71%&(8+9#3%3:+% 0$*(;#,<(=><(?9> >#+%34+<(@%&3%+(64+(@2#&#*2(*&$(A+*&52*3#4&*2(0&64+,*3#5 B&#"%+5#3C(46(@*2#64+&#*(;*&()+*&#54 =*C(D<(EF.. .G#39(39*&H5(34(I#9(J+*"#3K(=><(B@(>*"#5(*&$(L*#9:*(>:*&<(@42:,M#*
  • 2. I%19+*5#&-(N>4%5(#3(G4+HOP(Complexes of) Outcome Exposures strength of association? Increased Text4Baby individual breastfeeding population
  • 3. @:++%&3(811+4*9%5/(I@A Asthma App ER visits at 1 year 50 people 100 people Usual Care ER visits at 1 year 50 people populationQ A%535(1+%51%#R%$(#&3%+"%&3#4&5(*&$(4:34,%5Q A4(4&R+,(*(9C1439%5#5(*3(39%(141:2*3#4&(2%"%2Q ;3+4&-(#&3%+&*2("*2#$#3CQ ?+4M2%,5/(524S(34(5%3T:1<(%U1%&5#"%<(594+3T3%+,<(2*H +%2%"*&%(34(39%(+%*2(S4+2$
  • 4. @:++%&3(811+4*9%5/(>*3*(=#&#&- EHR Exposures Outcomes ? Apps populationQ !U145:+%5(*&$(4:34,%5(6+4,(*+%(1+4%55(5C53%,5Q A4(-%&%+*3%(9C1439%5%5(*3(39%(141:2*3#4&(2%"%2Q ?+4M2%,5/(2#,#3%$(34($*3*(422%3%$<(S%*H(#&3%+&*2 "*2#$#3C(V$*3*(&43(4,12%3%(4+(5C53%,*3#W
  • 5. @:++%&3(811+4*9%5/ LT46T.(;3:$#%5 Asthma app Usual Care Asthma app peak flow peak flow Usual Care Asthma app Usual Care individualQ G#39#&T5:MX%3(,:23#12%(+4554"%+Q 7&2C(64+,*2(,%394$(64+($%3%+,#&#&-(#&$#"#$:*2 3+%*3,%&3(%Y%3#"%&%55Q ?+4M2%,5/(4,12#*3%$(34(5%3(:1<(*&*2C5#5(#5 $#Z:23<(2#332%(H&4S&<(&43(S#$%2C(:5%$
  • 6. !"#$%&%(!U3+*3#4&Q !"#$%&%(#5(54,%39#&-(34(M%(%U3+*3%$ 6+4,(39%(*+%(1+4%55 [ ,#&#&-(#3(6+4,(39%($*3* [ $#+%32C(,*&#1:2*3#&-(39%(*+%(1+4%55(S#39 +#-#$(*&$(1+%T$%R&%$(1+434425
  • 7. !"#$%&%(;3+#1(=#&#&-
  • 8. !"#$%&%()*+,#&- Hay, et al. J Eval Clin Prac 14(2008):707-713.
  • 9. I443#&-(64+(!"#$%&%
  • 10. 0&$:53+#*2(!"#$%&%()*+,#&- Asthma App ER visits at 1 year 50 people100 people Usual Care ER visits at 1 year 50 people population
  • 11. ?%+54&*2(!"#$%&%(*+$%&5 Asthma app Usual Care Asthma app peak flow peak flow Usual Care Asthma app Usual Care individual
  • 12. ?%+54&*2(!"#$%&%(*+$%&5 Flovent Flovent PRN Flovent dancing dancing Flovent PRN Flovent Flovent PRN individual
  • 13. @+4S$54:+#&-(G9*3(=*33%+5Q V@4,12%U%5(46W(!U145:+%5 [ $4%5(9442*3%(3+#--%+(V,CW(*539,*O [ 3%53#&-(4,,4&(+%-#,%&5(V8@!0<(53*3#&<(MTM24H%+W< 4,12%,%&3*+C(,%$##&%5Q V@4,12%U%5(46W(7:34,%5 [ S9*3(4:34,%5($4(1*3#%&35(*+%(*M4:3O
  • 14. !"#$%&%(=*+45C53%,Rooting for Industrial Evidence Personal Evidence Evidence Farming Gardens
  • 15. ]4S(*&(S%(5*2%(%"*2:*3#4&O
  • 16. ;34"%1#1%$ ,]%*239Q ]%*239(*115(M:#23 #&$%1%&$%&32C [ 2#332%($*3*(59*+#&-(*&$ #&3%+41%+*M#2#3CQ ^#,#35(%Z#%&C(*&$ #,1*3(46(_:*2#3C ,]%*239
  • 17. 0&3%+&%3(]4:+-2*55(=4$%2Q ;3*&$*+$#K%(*&$ ,*H%(41%&(39% N&*++4S(S*#53PQ I%$:%5($:12#*3#4&< 51:+5(4,,:&#3C #&&4"*3#4&<(5:114+35 4,,%+#*2(*&$(&4&T 1+4R3(:5%5
  • 18. 71%&,]%*239`4+- Estrin DE, Sim I. Science; 330: 759-60. 2010.
  • 19. 71%&,]%*239`4+-Q A9%(S*#53(594:2$(5:114+3 39%(%"#$%&%(,*+45C53%,
  • 20. 71%&(8+9#3%3:+%(64+(*& !"#$%&%(=*+45C53%,Q =4$:2%5(64+(:5*-%(*&*2C3#5 [ a(46(3%U3(,%55*-%5<(a(46(5%55#4&5<(%3`Q I443#&-(64+(V-24*2W(%"#$%&% [ $*3*(59*+#&-(S#39(59*+%$(5C&3*U(*&$(5%,*&3#5Q 0&$:53+#*2(6*+,#&-<(%`-`<(S#39(I@A5 [ ,4$:2%5(64+(#&64+,%$(4&5%&3<(+*&$4,#K*3#4&<(*$*13#"% 3+%*3,%&3(53+*3%-C<(,#U%$(,%394$5<(%3`Q ?%+54&*2(%"#$%&%(-*+$%&#&-<(%`-`<(LT46T. [ ,4$:2%5(64+(5+#13#&-(*&$(*&*2CK#&-(#&$#"#$:*2#K%$(LT46T .(1+434425<(%3`
  • 21. 71%&(8+9#3%3:+%(64+(*& !"#$%&%(=*+45C53%,Q ;4#*2(,%$#*(64+($#54"%+C(46(%U145:+%5(*&$ 4:34,%5(39*3(,*33%+Q ;9*+%$(2#M+*+#%5(46("*2#$*3%$(,%*5:+%5(*&$ #&53+:,%&35(V%`-`<(?I7=0;W [ ,%*5:+%5(39*3(-%3(*3(R&%+T-+*#&%$(,%9*&#5,5(M*5%$ 4&(39%4+%3#*2(,4$%25(46(9*&-%<(%3`
  • 22. 4*2(64+(,]%*239(!"#$%&%Q 8(2%*+&#&-(4,,:&#3C(4:12%$(S#39(*& 41%&(*+9#3%3:+%(64+(M+4*$<(+*1#$<(*&$ #3%+*3#"%($#55%,#&*3#4&(46(%"*2:*3#4& ,%394$5(*&$(R&$#&-5(39*3(,*33%+
  • 23. Q 0$*(;#,(#$*`5#,b:56`%$:Q >%M4+*9(!53+#&($%53+#&b5`:2*`%$:Q 9331/cc41%&,9%*239`4+-c

×